Frequency of use and adequacy of Cochrane risk of bias tool 2 in non‐Cochrane systematic reviews published in 2020: Meta‐research study
Research Synthesis Methods · 2024
DOI: 10.1002/jrsm.1695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Synthesis Methods, 2024. Verfasst von Andrija Babić und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Emergency Medicine in Split-Dalmatia County, Split, Croatia. Hauptthemen laut MEDLINE: Bias, Systematic Reviews as Topic, Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Risk of bias (RoB) assessment is essential to the systematic review methodology. The new version of the Cochrane RoB tool for randomized trials (RoB 2) was published in 2019 to address limitations identified since the first version of the tool was published in 2008 and to increase the reliability of assessments. This study analyzed the frequency of usage of the RoB 2 and the adequacy of reporting the RoB 2 assessments in non‐Cochrane reviews published in 2020. This meta‐research study included non‐Cochrane systematic reviews of interventions published in 2020. For the reviews that used the RoB 2 tool, we analyzed the reporting of the RoB 2 assessment. Among 3880 included reviews, the Cochrane RoB 1 tool was the most frequently used ( N = 2228; 57.4%), followed by the Cochrane RoB 2 tool ( N = 267; 6.9%). From 267 reviews that reported using the RoB 2 tool, 213 (79.8%) actually used it. In 26 (12.2%) reviews, erroneous statements were used to indicate the RoB 2 assessment. Only 20 (9.4%) reviews presented a complete RoB 2 assessment with a detailed table of answers to all signaling questions. The judgment of risk of bias by the RoB 2 tool was not justified by a comment in 158 (74.2%) reviews. Only in 33 (14.5%) of reviews the judgment in all domains was justified in the accompanying comment. In most reviews (81.7%), the RoB was inadequately assessed at the study level. In conclusion, the majority of non‐Cochrane reviews published in 2020 still used the Cochrane RoB 1 tool. Many reviews used the RoB 2 tool inadequately. Further studies about the uptake and the use of the RoB 2 tool are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Emergency Medicine in Split-Dalmatia County, Split, Croatia.
- Department of Surgery, University Hospital Split, Split, Croatia.
- Department of Radiology, University Hospital Split, Split, Croatia.
- PZU MK & RR Centar Medikal, Bitola, Macedonia.
- Department of Ophthalmology, University Hospital Split, Split, Croatia.
- Department of General Medicine, Box Hill Hospital, Eastern Health, Box Hill, Australia.
ORCID-Profile: Andrija Babić, Ognjen Barcot, Tomislav Visković, Frano Šarić, Aleksandar Kirkovski, Ivana Barun, Zvonimir Križanac, Roshan Arjun Ananda, Yuli Viviana Fuentes Barreiro, Narges Malih, Daiana Anne-Marie Dimcea, Josipa Ordulj, Ishanka Weerasekara, Matteo Spezia, Marija Franka Žuljević, Jelena Šuto, Luca Tancredi, Anđela Pijuk, Susanna Sammali, Veronica Iascone, Thilo von Groote, Tina Poklepović Peričić, Livia Puljak
Zitieren
APA
Babić, A., Barcot, O., Visković, T., Šarić, F., Kirkovski, A., Barun, I., Križanac, Z., Ananda, R. A., Fuentes Barreiro, Y. V., Malih, N., Dimcea, D. A., Ordulj, J., Weerasekara, I., Spezia, M., Žuljević, M. F., Šuto, J., Tancredi, L., Pijuk, A., Sammali, S., …, & Puljak, L. (2024). Frequency of use and adequacy of Cochrane risk of bias tool 2 in non‐Cochrane systematic reviews published in 2020: Meta‐research study. Research Synthesis Methods. https://doi.org/10.1002/jrsm.1695
Vancouver
Babić A, Barcot O, Visković T, Šarić F, Kirkovski A, Barun I, et al. Frequency of use and adequacy of Cochrane risk of bias tool 2 in non‐Cochrane systematic reviews published in 2020: Meta‐research study. Research Synthesis Methods. 2024. doi:10.1002/jrsm.1695
BibTeX
@article{Babi2024,
author = {Babić, Andrija and Barcot, Ognjen and Visković, Tomislav and Šarić, Frano and Kirkovski, Aleksandar and Barun, Ivana and Križanac, Zvonimir and Ananda, Roshan Arjun and Fuentes Barreiro, Yuli Viviana and Malih, Narges and Dimcea, Daiana Anne-Marie and Ordulj, Josipa and Weerasekara, Ishanka and Spezia, Matteo and Žuljević, Marija Franka and Šuto, Jelena and Tancredi, Luca and Pijuk, Anđela and Sammali, Susanna and Iascone, Veronica and von Groote, Thilo and Poklepović Peričić, Tina and Puljak, Livia},
title = {Frequency of use and adequacy of Cochrane risk of bias tool 2 in non‐Cochrane systematic reviews published in 2020: Meta‐research study},
journal = {Research Synthesis Methods},
year = {2024},
doi = {10.1002/jrsm.1695}
}
EUVIMED